BlackBerry (NASDAQ:BBRY): Cleveland Research says channel checks are indicating that second-quarter unit sales are trending to 5 million to 6 million units against the consensus of 6 million to 7 million units, with inventory levels for the Q10 and Z10 higher than expected.
Allergan (NYSE:AGN): Wells Fargo notes that Allergan stated in its earnings release that due to a new Food and Drug Administration requirement, a Levadex refiling is now planned for end of 2013 as opposed to mid-year, with approval expected in the second quarter of 2014 instead of the end of 2013. Wells views the delay as a slight negative but calls the quarter and guidance solid.
InvenSense (NASDAQ:INVN): Pacific Crest increased its price target on InvenSense to $19 from $15 after the company reported results that the firm views as strong. Pacific Crest continues to expect that the company to win a deal with Apple (NASDAQ:AAPL), and it keeps an Outperform rating on the stock.
Chicago Bridge & Iron (NYSE:CBI): Sterne Agee believes that Chicago Bridge & Iron reported strong results and thinks that the company has several positive catalysts working in its favor. It keeps a Buy rating on the shares.